Clinical Trial Update: Silybin - Vitamin E- Phospholipids Complex Reduces Liver Fibrosis in Patients With Chronic Hepatitis C Treated With Peg-IFN-a and RBV [Phase 3]

View source ↗

Summary

Phase 3 trial suggests that the silybin-Vitamin E-Phospholipids complex reduces liver fibrosis in patients with chronic hepatitis C treated with Pegylated inter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Fibrosis

Drugs mentioned

• Silybin-Vitamin E-Phospholipids Complex (silibinin (silybin))

Snippet

Sponsor: University of Catania | Conditions: Liver Fibrosis | Phase 3 | Status: COMPLETED